Anzeige
Mehr »
Sonntag, 07.09.2025 - Börsentäglich über 12.000 News
Tokenisierung entfesselt: Republic führt die Ethereum-Revolution
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40Z8N | ISIN: US62818Q3020 | Ticker-Symbol: 2W6
NASDAQ
05.09.25 | 21:45
1,425 US-Dollar
-3,06 % -0,045
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
MUSTANG BIO INC Chart 1 Jahr
5-Tage-Chart
MUSTANG BIO INC 5-Tage-Chart

Aktuelle News zur MUSTANG BIO Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
08.08.MUSTANG BIO, INC. - 10-Q, Quarterly Report3
09.07.Pre-market Movers: Basel Medical Group, SOBR Safe, ProKidney, RxSight, Mustang Bio749OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green Basel Medical Group Ltd (BMGL) is up over 88% at...
► Artikel lesen
MUSTANG BIO Aktie jetzt für 0€ handeln
08.07.MBIO Soars on Orphan Drug Nod for Investigational Brain Cancer Therapy2
07.07.Mustang Bio Stock Soars 200% On FDA Orphan Drug Designation10
07.07.Dow Dips 1%; Mustang Bio Shares Spike Higher2
07.07.Mustang Bio rises after FDA orphan drug status for MB-1017
07.07.Mustang Bio-Aktie steigt stark an nach FDA-Sonderstatus für Hirntumor-Therapie19
07.07.Mustang Bio stock soars after FDA grants orphan drug designation1
07.07.FDA grants orphan drug status to Mustang Bio's glioma treatment8
07.07.Mustang Bio, Inc.: Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma259In an ongoing Phase 1 trial published in Nature Medicine, MB-101 was well-tolerated and 50% of patients achieved stable disease or better with two partial responses and two complete responses lasting...
► Artikel lesen
28.03.MUSTANG BIO, INC. - 10-K, Annual Report10
05.03.Mustang Bio, Inc.: Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement196WALTHAM, Mass., March 05, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. ("Mustang" or the "Company") (Nasdaq: MBIO) today announced that it has received notice from The Nasdaq Stock Market LLC ("Nasdaq")...
► Artikel lesen
27.02.Mustang Bio, Inc.: Mustang Bio Announces Sale of Fixed Assets and Exit of Facility531WALTHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. ("Mustang" or the "Company") (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs...
► Artikel lesen
11.02.Mustang Bio, Inc.: Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement211WORCESTER, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. ("Mustang" or the "Company") (Nasdaq: MBIO) today announced that it has received notice from The Nasdaq Stock Market LLC ("Nasdaq")...
► Artikel lesen
14.01.Mustang Bio, Inc.: Mustang Bio Announces Reverse Stock Split115WORCESTER, Mass., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. ("Mustang" or the "Company") (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today's medical...
► Artikel lesen
12.11.24Mustang Bio, Inc.: Mustang Bio Receives Positive Listing Determination from Nasdaq242WORCESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. ("Mustang" or the "Company") (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today's medical...
► Artikel lesen
07.11.24Mustang Bio, Inc.: Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma147MB-108 (HSV-1 oncolytic virus) is active and well tolerated in patients with recurrent glioblastoma in ongoing Phase 1 clinical trial Preclinical data support a novel combination of MB-108 (HSV-1...
► Artikel lesen
23.10.24Pre-market Movers: CNS Pharmaceuticals, Zapata Computing, Farmmi, Mustang Bio, Spirit Airlines732BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.35 A.M. ET).In the Green CNS Pharmaceuticals, Inc. (CNSP) is up over 143%...
► Artikel lesen
18 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1